{"DataElement":{"publicId":"2495787","version":"1","preferredName":"Medication Osteoporosis Administered Type","preferredDefinition":"the type of biologically active substance administered to reverse or slow the condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence.","longName":"MED_OSTEO_ADMIN_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2495785","version":"1","preferredName":"Medication Osteoporosis Administered","preferredDefinition":"information related to the administration of a biologically active substance to reverse or slow the condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence.","longName":"MED_OSTEO_ADMIN","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2411879","version":"1","preferredName":"Medication","preferredDefinition":"biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products.","longName":"C459","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"019C7266-B896-0AAA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-09-27","modifiedBy":"ONEDATA","dateModified":"2005-09-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2732414","version":"1","preferredName":"Osteoporosis Administered","preferredDefinition":"loss of bone mass and strength due to nutritional, metabolic, or other factors, usually resulting in deformity or fracture; a major public health problem of the elderly, especially women.:Given.","longName":"C3298:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoporosis","conceptCode":"C3298","definition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"474D90DF-5B1A-193C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-02-29","modifiedBy":"ONEDATA","dateModified":"2008-02-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"189E3AEC-4B26-457E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-12","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2495788","version":"1","preferredName":"Osteoporosis Medication Type","preferredDefinition":"the type of medication used for treated loss of bone density.","longName":"OSTEO_MED_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Biphosphonate","valueDescription":"Biphosphonate Therapy","ValueMeaning":{"publicId":"2580259","version":"1","preferredName":"Biphosphonate Therapy","longName":"2580259","preferredDefinition":"A family of drugs used to treat osteoporosis and the bone pain caused by some types of cancer. Also called diphosphonates.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biphosphonate","conceptCode":"C443","definition":"A drug or substance used to treat hypercalcemia (abnormally high blood calcium) and bone pain caused by some types of cancer. Forms of bisphosphonates are also used to treat osteoporosis and for bone imaging. Bisphosphonates inhibit a type of bone cell that breaks down bone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0690-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-15","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-15","modifiedBy":"REEVESD","dateModified":"2009-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"189E54EF-7D37-4993-E044-0003BA3F9857","beginDate":"2006-07-15","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-15","modifiedBy":"ALAIS","dateModified":"2006-07-15","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"189E54EF-7D43-4993-E044-0003BA3F9857","beginDate":"2006-07-15","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-15","modifiedBy":"ALAIS","dateModified":"2006-07-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"189E54DC-62DD-48A2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-15","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-15","modifiedBy":"REEVESD","dateModified":"2009-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"What drug","type":"Preferred Question Text","description":"What drug","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"If yes or continuing","url":null,"context":"CTEP"}],"origin":"NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"189E48BC-811B-3EC3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-15","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-07-15","modifiedBy":"SHIDED","dateModified":"2010-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}